Results 11 to 20 of about 73,449 (206)
Mild hyperphenylalaninemia: to treat or not to treat [PDF]
AbstractOne of the issues to be resolved in phenylketonuria is whether patients with mild hyperphenylalaninemia need treatment, or in other words, in what patients treatment needs to be started. Do patients need treatment when phenylalanine concentrations in blood are >360 μmol/L or >600 μmol/L? This paper reviews the literature on the outcome of
Francjan J. van Spronsen +1 more
openaire +4 more sources
DNAJC12-deficient hyperphenylalaninemia is a recently described inborn error of metabolism associated with hyperphenylalaninemia, neurotransmitter deficiency, and developmental delay caused by biallelic pathogenic variants of the DNAJC12 gene.
Colleen Donnelly +3 more
doaj +2 more sources
Psychopathological Risk Assessment in Children with Hyperphenylalaninemia
Background: Phenylketonuria (PKU) is a rare congenital disorder caused by decreased metabolism of phenylalanine determining cerebral impairments. If untreated, PKU might lead to intellectual disability, seizures and behavioral disorders.
Maria Cristina Risoleo +8 more
doaj +3 more sources
BH4-deficient hyperphenylalaninemia in Russia.
A timely detection of patients with tetrahydrobiopterin (BH4) -deficient types of hyperphenylalaninemia (HPABH4) is important for assignment of correct therapy, allowing to avoid complications.
Polina Gundorova +12 more
doaj +2 more sources
Cognitive functioning in mild hyperphenylalaninemia
Background: Hyperphenylalaninemia is a hereditary metabolic disorder that causes elevated blood phenylalanine (Phe). Hyperphenylalaninemias are classified as Phenylketonuria PKU (Phe > 6 mg/dL) or mild hyperphenylalaninemia (mHPA) (Phe 2–6 mg/dL).
Alicia de la Parra +4 more
doaj +2 more sources
Background The risk of neuropsychological disorders appears to be high in hyperphenylalaninemia (HPA). The hypothesis of executive function impairment is prominent in accounting for the neuropsychological phenotype in phenylketonuria (PKU) and is ...
Laetitia Paermentier +3 more
doaj +2 more sources
Genotype-phenotype corelation in Serbian patients with hyperphenylalaninemia [PDF]
Cilj rada: Ispitivana je korelacija genotipa i fenotipa bolesnika sa hiperfenilalninemijom. Utvrðena je incidencija hiperfenilalninemije u našoj populaciji. Prikazana je učestalost najčešćih mutacija u PAH genu i njihov uticaj na fenotip.
Đorđević, Maja
core +5 more sources
Integrating Functional Consequence Annotation With PAH Allelic Phenotype Values Refines Prediction of Tetrahydrobiopterin Responsiveness. [PDF]
ABSTRACT Tetrahydrobiopterin (BH4; sapropterin) responsiveness in phenylalanine hydroxylase (PAH) deficiency is genotype dependent, yet many patients remain untested. Allelic phenotype values (APV) summarize allele severity, but responsiveness can be heterogeneous within APV strata. We assessed whether integrating functional consequence annotation from
Himmelreich N, Blau N.
europepmc +2 more sources
Increased Brown Adipose Tissue Thermogenesis in Phenylketonuria. [PDF]
In phenylketonuria (PKU), elevated phenylalanine (Phe) increases hepatic fibroblast growth factor 21 (FGF21) and thyroid hormones, enhancing brown adipose tissue (BAT) thermogenesis in patients. Central FGF21 reproduces this phenotype in rodents via reduced hypothalamic AMP‐activated protein kinase (AMPK) activity in the ventromedial nucleus of the ...
López-Rey N +18 more
europepmc +2 more sources
Hyperphenylalaninemia and serotonin deficiency in Dnajc12-deficient mice [PDF]
Serotonin exerts numerous neurological and physiological actions in the brain and in the periphery. It is generated by two different tryptophan hydroxylase enzymes, TPH1 and TPH2, in the periphery and in the brain, respectively, which are members of the ...
Yunqing Cao +7 more
doaj +2 more sources

